Y-Intercept (HK)’s Charles River Laboratories CRL Stock Holding History

Y-Intercept (HK)’s Portfolio CRL Stock Details CRL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.18M	Buy
2025 Q2	–	Sell
2025 Q1	$566K	Buy
2023 Q3	–	Sell
2023 Q2	$2.25M	Buy
2023 Q1	$488K	Buy
2022 Q3	–	Sell
2022 Q2	$1.19M	Buy
2022 Q1	$236K	Buy